Cytomegalovirus-Based Viral Vectors Elicit Robust Systemic and Tissue-Resident Immune Response Against SARS-CoV-2 Antigens
{{output}}
Current COVID-19 vaccines face challenges such as waning immunity and limited mucosal protection. These limitations highlight the importance of developing next-generation vaccines that can induce strong tissue-specific and systemic immune responses. Cytomegalo... ...
